A patient preference evaluation study of fluticasone furoate nasal spray and fluticasone propionate aqueous nasal spray in subject with allergic rhinitis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 27 Jun 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Fluticasone furoate (Primary) ; Fluticasone propionate
Indications Allergic rhinitis; Perennial allergic rhinitis; Seasonal allergic rhinitis
Focus Therapeutic Use
Sponsors GlaxoSmithKline; GSK

01 Mar 2013 Actual end date 31 Dec 2006 added as reported by ClinicalTrials.gov.
13 May 2008 Status change
15 Dec 2006 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com